Robert Ramirez, DO
Dr. Robert Ramirez is a medical oncologist specializing in treating thoracic and neuroendocrine malignancies at Vanderbilt University Medical Center in Nashville, Tennessee. As a member of the Division of Hematology and Oncology, his focus is on neuroendocrine tumors, lung cancers, and other thoracic malignancies.[1]
Dr. Ramirez is helping to expand Vanderbilt University’s established NET program while focusing on general thoracic oncology and thoracic neuroendocrine tumors. He is also actively involved in educating and mentoring the next generation of oncologists.
Education and Career
Dr. Ramirez earned his Doctor of Osteopathic Medicine degree at the University of Medicine and Dentistry of New Jersey School of Medicine. From there he completed his internship and residency in Internal Medicine at Cooper University Hospital in Camden, New Jersey, and then completed a combined Hematology and Medical Oncology fellowship at the University of Tennessee Health Sciences Center in Memphis, Tennessee, where he was selected to be Chief Fellow.[1]
Following his medical education and training, Dr. Ramirez spent time treating patients at Ochsner Health‘s Gayle and Tom Benson Cancer Center, splitting his time between clinical and research duties at the Ochsner Lung Cancer Multidisciplinary Program and the Ochsner Kenner/LSU Multidisciplinary Neuroendocrine Clinic.
Professional Memberships and Activities
Dr. Ramirez is an active member of several respected medical and professional organizations and has taken on leadership roles in several. He is a Fellow of the American College of Physicians and a member of the International Association for the Study of Lung Cancer, where he also serves as a member of the Communications Committee. He is also a member of the American Society of Clinical Oncology and a member of the Nominating Committee and the Scientific Review and Research Committee of the North American Neuroendocrine Tumor Society.[1]
Research
Dr. Ramirez is active in clinical trial design and investigator-initiated trials focused on his research interest in novel therapies for the treatment of non-small cell and small cell lung cancers and neuroendocrine tumors. He has authored or co-authored over 99 articles published in respected medical journals and has presented abstracts and lectures at both national and international conferences and meetings.
Dr. Ramirez’s recent publications include:[2]
- Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER d… Lin, Z., Chen, Y., Liu, C., Panzuto, F., Lang, M., Kim, H., Ding, Z., Ramirez, R.>; Journal of Gastrointestinal Oncology. 2023 Dec 31
- Identification and Characterization of Avoidable Hospital Admissions in Patients with Lung Cancer. Eric M Lander, Xuanyi Li, Li-Ching Huang, Amanda S Cass, Wade T Iams, Emily A Skotte, Jennifer G Whisenant, Robert A Ramirez, Sally J York, Travis J Osterman, Jennifer…>; Journal of the National Comprehensive Cancer Network. 2023 Oct 1
- A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review. Robert A Ramirez, Amanda S Cass, Satya Das, See-Wei Low, Mitra Mehrad, Otis B Rickman, Philip M Scherer, Katharine E Thomas, Erin A Gillespie>; Translational Lung Cancer Research. 2022 Dec 1
